- Home
- BVS vs DGICA Comparison
BVS vs DGICA Comparison
Compare BVS & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVS | DGICA |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | United States |
| Employees | N/A | 851 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.8M | 607.2M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | BVS | DGICA |
|---|---|---|
| Price | $9.50 | $18.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $14.00 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 653.3K | 111.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $2.26 |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $232.25 | ★ $7.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $16.11 |
| 52 Week High | $11.25 | $21.06 |
Technical Indicators
Market Signals| Indicator | BVS | DGICA |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 68.80 |
| Support Level | $8.43 | $18.05 |
| Resistance Level | $11.00 | $19.48 |
| Average True Range (ATR) | 0.37 | 0.39 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 79.41 | 89.36 |
Price Performance
Historical ComparisonAbout BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.